Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!
Welcome to yet another exciting month and a most pleasant Reading of our newsletter.
Please do not hesitate to mail your comments on this edition to help us further improve so please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
“If you look at the data from Delhi, it does suggest that we seem to have flattened the curve and, maybe, are showing a downward trend. So, it is possible that we have crossed the peak as far as Delhi is concerned. We still need to be very careful.The infection has not gone away totally, but it has come down. We have to continue to sustain (this) by following social distancing, wearing masks, and close surveillance so that if there is a small cluster developing somewhere, it does not become an area of spread. All those measures which are being followed need to be aggressively followed even in the coming weeks so that we don’t see a resurgence of cases”
Dr Randeep Guleria
Director
All India Institute of Medical Sciences (AIIMS)
Sponsor
Patient Safety Capsules
India’s Pain Eases As China Resumes Bulk Drug Supplies
New Delhi, 24 July 2020: Supplies of bulk drugs from China are back to normal, easing concerns of India’s pharmaceutical industry that has been facing a shortage and rising cost of the raw material since the start of the coronavirus outbreak.
DoP Notifies Scheme For Promoting Bulk Drug Parks & Making India Self-Reliant In Producing APIs
Mumbai, 23 July 2020: The Department of Pharmaceuticals (DoP) has come out with notification for Rs, 3,000 crore bulk drug parks’ promotion scheme and Rs. 6,940 crore production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical key starting materials (KSMs)/ drug intermediates (DIs) and active pharmaceutical ingredients (APIs) in India.
Drug Laws & Policy Injections
Supreme Court Allows Service Of Summons Via WhatsApp, Email, FaxNew Delhi, 10 July 2020: In a first, the Supreme Court on Friday allowed the service of summons and notices, a necessity in almost all legal proceedings, through instant messenger like WhatsApp as well as by e-mail and fax.
BIS Starts Testing Of FFP2 Grade Masks At Venus Safety And Health, Panvel Mumbai, 24 July 2020: The Bureau of Indian Standards (BIS) has started indigenous FFP2 masks testing for quality control assurance at Venus Safety and Health Laboratory located at Panvel near Mumbai. These masks, also called respiratory protective device filter half masks, have been found to be effective to protect frontline healthcare workers from COVID-19 infection.
New Rules For Electronic Retailers To Be Effective By This Week: PaswanNew Delhi, 21 July 2020 : The new rules for electronic retailers, including mandatory display of 'country of origin' on their products, will come into force by the end of this week, Union minister Ram Vilas Paswan said on Monday and emphasised that the entities will face penal action for any non-compliance.
DoP Notifies PLI Scheme For Promoting Domestic Manufacturing Of Medical DevicesMumbai, 23 July 2020: The Department of Pharmaceuticals (DoP) has finally notified Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices through a gazette notification dated July 21, 2020. Total financial outlay of the Scheme is Rs. 3,420 crore.
Gujarat Nod For 92 Firms To Make Immunity BoostersAHMEDABAD, 24 JULY 2020: With demand for vitamin C and D spurting drastically amid unprecedented rush for immunity boosters, more and more firms have ventured into manufacturing of these micronutrients since the outbreak of Covid-19.
Centre Amends Export Policy Of Medical Coveralls, Removes Surgical Drapes, Wraps From Prohibition ListNew Delhi, 22 July 2020: The Centre on Tuesday amended the export policy of medical coveralls of all classes under which the export of all masks other than non-medical/non-surgical masks, and personal protection equipment (PPEs) will remain banned.
Pharma Injections
Inhumane To Profiteer: Doctor Who Spotted Fake DrugAHMEDABAD, 24 JULY 2020: Dr Devang Shah couldn’t feel greater Hippocratic satisfaction that he spent the intervening night of July 11 and 12 gathering evidence on his hunch that a life-saving Covid drug was a dangerous fake. Dr Shah is a physician involved in Covid care in two private hospitals of the city.
Crime Branch To Probe Fake Tocilizumab CaseAhmedabad, 23 July 2020: The case of the rebranding and selling synthetic steroids as Covid-19 drug Crime Branch to probe fake Tocilizumab case was on Wednesday handed over to the Ahmedabad Crime Branch for investigation, a day after an FIR for attempted murder was filed against five accused at Vastrapur police station.
Glenmark Slams Allegations On Fabiflu As Careless, Unsubstantiated New Delhi, 21 July 2020: In a strong rebuttal to the drug regulator, Glenmark Pharma said it has been at the receiving end of careless, unsubstantiated allegations that are devoid of merits related to Covid drug, Fabiflu.
Haryana''S NCB Will Have Units At 17 Places In The State, HQ In Karnal: Anil Vij Chandigarh, 20 Jul 2020: Haryana's Narcotics Control Bureau will have its units at 17 places in the state with the headquarters proposed to be set up at Madhuban in Karnal district, state Home Minister Anil Vij said here on Monday.
High-Level Panel Suggests Single-Window System For New Drug Approvals New Delhi, 21 July 2020: A high-level committee has proposed a single-window approval system to speed up availability of new drugs in the country, even as the world is in a rush to nd vaccine and cure for the Covid-19 pandemic.
NPPA Directs Manufacturers & Importers Of Orthopaedic Knee Implants To Furnish Price Data By July 26 Mumbai, 21 July 2020: The National Pharmaceutical Pricing Authority (NPPA) has directed companies manufacturing and importing orthopaedic knee implants to furnish price data by July 26, 2020 for price monitoring purpose.
Drug Dopes
Mumbai: Five Arrested For Selling Remdesivir, Tocilizumab Injections On Black MarketMumbai, 23 July 2020: Thane police on Wednesday arrested five persons in connection with black marketing of Remdesivir and Tocilizumab injections, used in Covid-19 treatment. 
Punjab: Notice To 50 Firms Over Hazardous SanitisersChandigarh, 22 July 2020: Initiating action against the manufacturers of hand sanitisers containing high amount of methanol, the state’s Food and Drug Administration (FDA) has cancelled the permission of a firm and initiated the process to act against two others.
DCA In Telangana Fails To Control Black Marketers Hyderabad, 21 July 2020: The state drug control administration (DCA) in Telangana has failed in its efforts to control the black marketers and pharmacy stores which are selling essential anti-viral drugs like remdesivir and tocilizumab, which are being sold at exorbitant rates than the stipulated selling price by the government.
DGFT Revises Approval Procedure For PPE Medical Coveralls' Export New Delhi, 20 Jul 2020: The commerce ministry has revised the procedure and criteria for submission and approval of applications for export of PPE medical coveralls for COVID-19 as all the requests filed by exporters for shipments in July were found ineligible, according to a trade notice issued on Monday.
Haryana: Man Held With Narcotic Drugs In Ambala AMBALA, 19 JULY 2020: Ambala police on Saturday arrested a man after recovering 2,656 narcotic capsules and tablets from his possession under limits of Mahesh Nagar police station.
Remdesivir Sold At 8 Times Its Price In Delhi: Agra ChemistsAGRA, 19 JULY 2020: In the wake of the rising demand for experimental Covid-19 medicine Remdesivir, Agra chemists have alleged that major dealers in Delhi are selling the drug for eight times its price, amid a supply crunch.
National Injections
India May Start Exporting Ventilators: Piyush Goyal New Delhi, 21 July 2020: Commerce and industry minister Piyush Goyal on Monday said India might soon start exporting ventilators citing lower requirement and use compared to earlier projections of the life-saving machines.
Inappropriate Use Of N95 Masks, That Contain Respiratory ValvesNew Delhi, 21 July 2020: The health ministry today has warned against "inappropriate use of N95 masks, especially those that contain respiratory valves" by the citizens. In a letter to all states and union territories, Rajiv Garg, the director general of health services, ministry of health said "It is to bring to your knowledge that the use of valved respirator N95 masks is detrimental to the measures adopted for preventing the spread of coronavirus as it does not prevent the virus from escaping out of the mask."
MoU Signed To Manufacture Medical Devices VIJAYAWADA, 19 JULY 2020: AP MedTech Zone (AMTZ) has entered into an agreement with the US-based Amphenol for establishing its facility in AMTZ to manufacture sensors, power electronics and medical sub-assemblies.
Special Teams To Inspect Pharma City From Today VISAKHAPATNAM, 19 JULY 2020: Tourism Minister Muttamsetti Srinivasa Rao alias Avanthi on Saturday said industries should not compromise on safety and they should follow the Standard Operating Procedures (SOPs) and guidelines issued by the government. Any violation will not be tolerated, he warned.
The Consumer Protection Act 2019 May Alter Ads' Landscape Mumbai, 20 July 2020: Indian advertising is headed for an overhaul, with a law designed to protect consumers from misleading ads in the age of online buying—fortuitous amid the pandemic—coming in to force on Monday.
Health Supplements And Nutraceuticals Containing PABA, A Banned Ingredient New Delhi, 18 July 2020: The Food Safety and Standards Authority of India (FSSAI) has issued a letter to all Commissioners of Food Safety of all States, UTs and Central Licensing Authorities about Surveillance and enforcement to prohibit sell of Health Supplements and nutraceutical products containing PABA (Para Amino Benzoic Acid) a banned ingredient.
Global Injections
Police Seize Fake COVID Kits Across Dozens Of CountriesLYON, France, 22 July 2020: A total of 17,000 fake COVID-19 test kits were seized during an operation coordinated by Interpol and Europol against trafficking in potentially dangerous drinks, food and medical products, the international police organization said on Wednesday.
Oxford University COVID-19 Vaccine Produces Strong Antibodies; T-Cell Oxford, UK, 20 July 2020: Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
New Regulation For Faster Vaccines And Treatments For COVID-19 Adopted By EU
Brussels, 11 July 2020: Members of the European Parliament (MEPs) have adopted a new regulation that will allow vaccines and treatments for COVID-19 to be developed more quickly.
Russia Accused Of Vaccine Hacking As India Locks Down 125 Million
London, 16 July 2020: Russia was accused Thursday of trying to steal coronavirus vaccine research as the pandemic surged across the world and more than 125 million people in India were put under a new lockdown.
Covid Is Spreading In Unexplained Ways, Dimming Containment Hope
New York, 16 July 2020: As countries across Asia Pacific struggle with resurgences of the COVID-19, one data point is steering government responses: the share of cases with no clear indication of how infection occurred.
Russia 1st Nation To Finish Human Trials For Covid-19 Vaccine
MOSCOW, 13 JULY 2020: Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication's effectiveness, the media reported on Sunday.
PSAIIF PILL
All Pharma Products Could Come With QR Codes In Bid To Ensure Authenticity
NEW DELHI, 16 JULY 2020: Medicine packs will soon have to bear a unique quick response (QR) code in an attempt to ensure authenticity and enable tracking. A committee has been set up to fine-tune the modalities, people aware of the matter said.
Clarification On Issue Of GST Rate On Hand Sanitizers
New Delhi, 15 July 2020: "The issue of GST rate on alcohol based hand sanitizers has been reported in few sections of media." says a press release from Ministry of Finance.
Frequently Asked Questions
Could 'Indiscriminate Use Of Remdesivir, Tocilizumab On Covid Patients Cause More Harm Than Good' ?
NEW DELHI, 12 JULY 2020: The Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on Covid-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good". Read More>>>
SUBSCRIBER'S SYMPTOM
Consumer Protection Act Kicks In From July 20
New Delhi, 17 July 2020: Most provisions of the Consumer Protection Act, 2019, will come into force from July 20, even though the government has not taken a decision on provisions relating to e-commerce, including its definition, and those relating to the constitution of an apex Central Consumer Protection Authority at the national level.
Blog Addicts
Mr Anand Pandit, MD Excellent articles that make very good reading. Well done.
Mr Hari Singh, IT ProfessionalThe Prescription is very well presented with extremely useful information for readers.
Ms Shreya Bhasin, Professional
Good newsletter which brings an in depth understanding of news events in the Pharma world both nationally and globally. Keep up the good work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
